News
The company’s shares jumped 15% in the wake of the trials which showed the pill, called orforglipron, helped patients with Type 2 diabetes lose weight at ... could be made commercially ...
Eli Lilly (LLY) CEO Dave Ricks said Friday that the company will make its planned GLP-1 weight-loss pill in the U.S. amid ... four domestic manufacturing plants. Lilly expects to file for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results